INTERNATIONAL EMBRYO TECHNOLOGY SOCIETY (EIN 510173101) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1975

Legal Domicile

Principal Officer

JEREMY HOLZNER

Phone

2173563182

Tax Period

2024-07-01 to 2025-06-30

INTERNATIONAL EMBRYO TECHNOLOGY SOCIETY, founded in 1975, is a small nonprofit that reported $617K in total revenue in fiscal year 2024. Revenue surged 22% from the prior year, signaling strong growth momentum. The organization ran a surplus of $128K, a strong 21% operating margin.

Mission

FURTHER THE SCIENCE OF EMBRYO TRANSFER RESEARCH THROUGH PROMOTION OF SCIENTIFIC RESEARCH AND DISSEMINATION OF SCIENTIFIC AND EDUCATIONAL INFO.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $129,592

Program Service Revenue $408,826

Investment Income $50,121

Other Revenue $28,289

TOTAL REVENUE $616,828

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $429,016

TOTAL EXPENSES $489,063

Year-over-Year Comparison

	2024	2023	Change
Revenue	$616,828	$505,083	+0.2%
Expenses	$489,063	$623,000	-0.2%
Net Income	$127,765	$-117,917	-2.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BEATRIZ FERNANDEZ-FUERTES	GOVERNOR	2.00	Director	$0	$0	$0
SATOKO MATOBA	GOVERNOR	2.00	Director	$0	$0	$0
TRUDEE FAIR	GOVERNOR	2.00	Director	$0	$0	$0
JOAO H VIANA	GOVERNOR	2.00	Director	$0	$0	$0
MARC-ANDRE SIRARD	PRESIDENT	2.00	Officer Director	$0	$0	$0
BRAD LINDSEY	TREASURER	2.00	Officer Director	$0	$0	$0
ANN VAN SOOM	VICE PRESIDENT	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$616,828	$489,063	$929,778	$127,765
2024	$505,083	$623,000	$846,841	$-117,917
2023	$262,633	$402,613	$831,198	$-139,980
2022	$301,103	$378,051	$806,130	$-76,948
2021	$168,130	$163,879	$1,025,193	$4,251
2020	$313,351	$456,162	$873,049	$-142,811
2019	$374,088	$323,057	$1,049,097	$51,031

INTERNATIONAL EMBRYO TECHNOLOGY SOCIETY